Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
hAfwc8Bw68V6vRLy
Listen
